Taiwan FDA registration dab6fceb7f617c9d62f6a71a84882f43

"Mediflora" all-in-one substance abuse screening test kit

TW: “麥迪弗若拉” 多合一藥物濫用篩檢測試盒

Taiwan·Risk Class 2·FIRSTEP BIORESEARCH INC.·Registered Dec 08, 2017 – Dec 23, 2019Cancelled

Registration details

Analysis ID: dab6fceb7f617c9d62f6a71a84882f43

Company information

Manufacturer: FIRSTEP BIORESEARCH INC.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: FIRSTEP BIORESEARCH INC.

Product details

Intended Use: 利用免疫定性分析法,檢驗人體尿液中之AMP, BAR, BZD, COC, MDMA, MET, MOR, PCP, THC, KET, MTD, BUP, PPX, TCA, K2, NMZ及其代謝物. 本產品可供專業人員及一般人士使用.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.3910 Tricyclic antidepressant test system;; A.3700 Prpasifene test system;; A.3610 Methamphetamine testing system
Import Information: Domestic

Dates and status

Registration Date: Dec 08, 2017
Expiry Date: Dec 23, 2019
Cancellation Date: Jul 15, 2022

Cancellation information

Status: Logged out
Reason: 未展延而逾期者

About this record

Access comprehensive regulatory information for "Mediflora" all-in-one substance abuse screening test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dab6fceb7f617c9d62f6a71a84882f43 and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.